Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Huntington Disease | 13 | 2022 | 145 | 2.170 |
Why?
|
| Nerve Tissue Proteins | 13 | 2024 | 1167 | 1.100 |
Why?
|
| Huntingtin Protein | 13 | 2022 | 65 | 1.040 |
Why?
|
| Drosophila melanogaster | 14 | 2025 | 844 | 0.880 |
Why?
|
| tau Proteins | 6 | 2025 | 240 | 0.790 |
Why?
|
| Drosophila | 20 | 2025 | 828 | 0.780 |
Why?
|
| Alzheimer Disease | 8 | 2025 | 882 | 0.620 |
Why?
|
| Nuclear Proteins | 7 | 2016 | 1351 | 0.600 |
Why?
|
| Spinocerebellar Ataxias | 6 | 2022 | 254 | 0.600 |
Why?
|
| Drosophila Proteins | 7 | 2025 | 773 | 0.570 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2017 | 79 | 0.550 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 110 | 0.550 |
Why?
|
| Tauopathies | 3 | 2024 | 78 | 0.510 |
Why?
|
| alpha-Synuclein | 4 | 2025 | 134 | 0.490 |
Why?
|
| Disease Models, Animal | 21 | 2025 | 4800 | 0.480 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 608 | 0.450 |
Why?
|
| Neurons | 9 | 2023 | 2050 | 0.440 |
Why?
|
| Ataxin-1 | 7 | 2022 | 162 | 0.430 |
Why?
|
| Parkinson Disease | 4 | 2025 | 740 | 0.400 |
Why?
|
| Neurodegenerative Diseases | 2 | 2022 | 284 | 0.370 |
Why?
|
| Animals | 36 | 2025 | 36524 | 0.370 |
Why?
|
| Brain | 9 | 2025 | 3225 | 0.350 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 3 | 2015 | 49 | 0.340 |
Why?
|
| Myotonic Dystrophy | 2 | 2013 | 151 | 0.310 |
Why?
|
| Neuropeptides | 1 | 2009 | 116 | 0.310 |
Why?
|
| RNA Interference | 5 | 2019 | 549 | 0.300 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2021 | 104 | 0.280 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 2 | 2021 | 38 | 0.280 |
Why?
|
| Peptides | 6 | 2022 | 864 | 0.280 |
Why?
|
| Cerebellum | 2 | 2022 | 467 | 0.280 |
Why?
|
| Corpus Striatum | 6 | 2022 | 97 | 0.260 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 623 | 0.250 |
Why?
|
| Transcription Factors | 4 | 2021 | 2735 | 0.250 |
Why?
|
| Autophagy | 2 | 2021 | 431 | 0.250 |
Why?
|
| Friedreich Ataxia | 2 | 2016 | 48 | 0.240 |
Why?
|
| Proteolysis | 2 | 2017 | 198 | 0.240 |
Why?
|
| Ubiquitin | 1 | 2006 | 151 | 0.240 |
Why?
|
| Animals, Genetically Modified | 7 | 2023 | 344 | 0.240 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2006 | 128 | 0.240 |
Why?
|
| Cells, Cultured | 6 | 2021 | 3181 | 0.220 |
Why?
|
| Gene Regulatory Networks | 3 | 2021 | 400 | 0.220 |
Why?
|
| Mice | 18 | 2024 | 19048 | 0.220 |
Why?
|
| Cell Line | 6 | 2021 | 2866 | 0.210 |
Why?
|
| Fibroblasts | 2 | 2018 | 918 | 0.210 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 393 | 0.210 |
Why?
|
| Haploinsufficiency | 1 | 2025 | 274 | 0.210 |
Why?
|
| Neuroglia | 2 | 2023 | 215 | 0.200 |
Why?
|
| ras Proteins | 2 | 2013 | 146 | 0.190 |
Why?
|
| Amyloid beta-Peptides | 2 | 2025 | 245 | 0.190 |
Why?
|
| Transcriptome | 4 | 2025 | 1134 | 0.180 |
Why?
|
| Electrical Synapses | 1 | 2021 | 13 | 0.180 |
Why?
|
| Ataxins | 4 | 2013 | 114 | 0.180 |
Why?
|
| Apolipoprotein E2 | 1 | 2020 | 15 | 0.170 |
Why?
|
| Apolipoprotein E4 | 1 | 2020 | 48 | 0.170 |
Why?
|
| Mutation | 9 | 2024 | 6350 | 0.170 |
Why?
|
| Brain Stem | 1 | 2021 | 119 | 0.170 |
Why?
|
| DNA-Binding Proteins | 2 | 2021 | 2178 | 0.160 |
Why?
|
| Behavior, Animal | 3 | 2021 | 522 | 0.160 |
Why?
|
| Humans | 34 | 2025 | 134223 | 0.160 |
Why?
|
| Proteomics | 2 | 2016 | 604 | 0.160 |
Why?
|
| Mice, Transgenic | 7 | 2024 | 2538 | 0.160 |
Why?
|
| Cell Nucleus | 2 | 2016 | 691 | 0.160 |
Why?
|
| Protein Kinase C beta | 1 | 2019 | 21 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2025 | 3508 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 400 | 0.150 |
Why?
|
| Sex Factors | 1 | 2023 | 1388 | 0.150 |
Why?
|
| Synaptic Transmission | 1 | 2021 | 365 | 0.150 |
Why?
|
| Protein Kinases | 2 | 2019 | 345 | 0.150 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2018 | 232 | 0.150 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2019 | 134 | 0.150 |
Why?
|
| Amyloidosis | 1 | 2019 | 73 | 0.140 |
Why?
|
| Models, Biological | 2 | 2017 | 1538 | 0.140 |
Why?
|
| DNA Damage | 1 | 2021 | 547 | 0.140 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2017 | 31 | 0.140 |
Why?
|
| Muscles | 2 | 2009 | 280 | 0.140 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2016 | 16 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2024 | 1621 | 0.120 |
Why?
|
| Antioxidants | 2 | 2016 | 373 | 0.120 |
Why?
|
| Oxidative Stress | 3 | 2016 | 874 | 0.120 |
Why?
|
| Dynamin I | 1 | 2015 | 3 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 424 | 0.120 |
Why?
|
| Genome | 1 | 2018 | 529 | 0.120 |
Why?
|
| Repressor Proteins | 2 | 2016 | 874 | 0.110 |
Why?
|
| Mutant Proteins | 1 | 2014 | 120 | 0.110 |
Why?
|
| Introns | 1 | 2015 | 319 | 0.110 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 259 | 0.110 |
Why?
|
| Phosphorylation | 4 | 2021 | 1715 | 0.110 |
Why?
|
| Sirolimus | 1 | 2015 | 239 | 0.100 |
Why?
|
| Iron | 1 | 2016 | 305 | 0.100 |
Why?
|
| Genomics | 2 | 2023 | 1678 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 315 | 0.100 |
Why?
|
| Diacylglycerol Kinase | 1 | 2012 | 15 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 212 | 0.090 |
Why?
|
| Phenotype | 2 | 2020 | 4611 | 0.090 |
Why?
|
| HEK293 Cells | 3 | 2021 | 825 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1922 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2016 | 1075 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2025 | 2948 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 68 | 0.080 |
Why?
|
| Ganglia | 1 | 2009 | 20 | 0.080 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 3800 | 0.080 |
Why?
|
| Transgenes | 2 | 2013 | 346 | 0.080 |
Why?
|
| Neurosecretory Systems | 1 | 2009 | 23 | 0.080 |
Why?
|
| Neurites | 1 | 2009 | 46 | 0.080 |
Why?
|
| Signal Transduction | 4 | 2021 | 4938 | 0.080 |
Why?
|
| Mushroom Bodies | 1 | 2009 | 48 | 0.080 |
Why?
|
| Genome-Wide Association Study | 3 | 2025 | 1880 | 0.080 |
Why?
|
| Larva | 1 | 2009 | 262 | 0.080 |
Why?
|
| Neurotransmitter Agents | 1 | 2009 | 150 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 389 | 0.080 |
Why?
|
| Male | 9 | 2025 | 66216 | 0.070 |
Why?
|
| Female | 10 | 2025 | 72055 | 0.070 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2007 | 11 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2009 | 283 | 0.070 |
Why?
|
| Protein Stability | 2 | 2021 | 175 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2021 | 367 | 0.070 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2006 | 13 | 0.060 |
Why?
|
| CELF1 Protein | 1 | 2006 | 50 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2006 | 272 | 0.060 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2006 | 59 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2006 | 143 | 0.060 |
Why?
|
| Iron-Binding Proteins | 2 | 2016 | 33 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2025 | 3678 | 0.060 |
Why?
|
| Aging | 2 | 2023 | 1308 | 0.060 |
Why?
|
| Molecular Chaperones | 1 | 2006 | 174 | 0.060 |
Why?
|
| Protein Folding | 1 | 2006 | 222 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 485 | 0.060 |
Why?
|
| Eye | 1 | 2006 | 245 | 0.060 |
Why?
|
| Paralysis | 1 | 2024 | 29 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2006 | 874 | 0.050 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2023 | 7 | 0.050 |
Why?
|
| Glucosylceramidase | 1 | 2023 | 27 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2021 | 2793 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 298 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 721 | 0.050 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2023 | 19 | 0.050 |
Why?
|
| Mice, Neurologic Mutants | 2 | 2014 | 74 | 0.050 |
Why?
|
| Transglutaminases | 1 | 2022 | 27 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 1333 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2024 | 4011 | 0.050 |
Why?
|
| Motor Activity | 2 | 2015 | 531 | 0.050 |
Why?
|
| Lysosomes | 1 | 2023 | 266 | 0.040 |
Why?
|
| Trinucleotide Repeats | 1 | 2021 | 111 | 0.040 |
Why?
|
| Locomotion | 1 | 2021 | 64 | 0.040 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2021 | 83 | 0.040 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2021 | 85 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 4883 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2021 | 673 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2006 | 2915 | 0.040 |
Why?
|
| Gene Expression | 2 | 2015 | 1622 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2019 | 97 | 0.040 |
Why?
|
| Mitochondria | 2 | 2016 | 759 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2019 | 69 | 0.040 |
Why?
|
| Homozygote | 1 | 2020 | 571 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 598 | 0.040 |
Why?
|
| Heterozygote | 1 | 2020 | 732 | 0.040 |
Why?
|
| Species Specificity | 1 | 2018 | 570 | 0.030 |
Why?
|
| Aluminum | 1 | 2016 | 12 | 0.030 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2016 | 36 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2021 | 936 | 0.030 |
Why?
|
| Manganese | 1 | 2016 | 61 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 319 | 0.030 |
Why?
|
| Copper | 1 | 2016 | 75 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 434 | 0.030 |
Why?
|
| Zinc | 1 | 2016 | 143 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2016 | 127 | 0.030 |
Why?
|
| Aconitate Hydratase | 1 | 2015 | 13 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2015 | 62 | 0.030 |
Why?
|
| Aldehydes | 1 | 2015 | 31 | 0.030 |
Why?
|
| Thioxanthenes | 1 | 2014 | 2 | 0.030 |
Why?
|
| Postmortem Changes | 1 | 2014 | 13 | 0.030 |
Why?
|
| Fear | 1 | 2016 | 205 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2014 | 39 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 1041 | 0.030 |
Why?
|
| Morpholines | 1 | 2014 | 64 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 131 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1945 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 185 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2019 | 738 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 230 | 0.030 |
Why?
|
| Glutathione | 1 | 2015 | 201 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 182 | 0.030 |
Why?
|
| Longevity | 1 | 2015 | 159 | 0.030 |
Why?
|
| NEDD8 Protein | 1 | 2013 | 12 | 0.030 |
Why?
|
| Cullin Proteins | 1 | 2013 | 15 | 0.030 |
Why?
|
| Ubiquitins | 1 | 2013 | 46 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2014 | 458 | 0.030 |
Why?
|
| Farnesyltranstransferase | 1 | 2012 | 9 | 0.030 |
Why?
|
| Myoblasts | 1 | 2013 | 38 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 482 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2015 | 1138 | 0.020 |
Why?
|
| Caspase 7 | 1 | 2012 | 9 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2019 | 1105 | 0.020 |
Why?
|
| Aged | 2 | 2025 | 21822 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2012 | 141 | 0.020 |
Why?
|
| Homeostasis | 1 | 2016 | 751 | 0.020 |
Why?
|
| Triazoles | 1 | 2012 | 142 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 197 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 324 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 3057 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 680 | 0.020 |
Why?
|
| Histones | 1 | 2014 | 572 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 467 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 718 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 407 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 169 | 0.020 |
Why?
|
| Risk Factors | 1 | 2025 | 11196 | 0.020 |
Why?
|
| Caspases | 1 | 2010 | 168 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 251 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2012 | 419 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 260 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 628 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 1099 | 0.020 |
Why?
|
| Adult | 2 | 2023 | 31963 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3978 | 0.020 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2007 | 17 | 0.020 |
Why?
|
| Genes, Insect | 1 | 2007 | 126 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2007 | 253 | 0.020 |
Why?
|
| Genome, Human | 1 | 2012 | 1350 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 514 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 2669 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 1436 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 7600 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 29431 | 0.010 |
Why?
|